BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lemoine L, Sugarbaker P, Van der Speeten K. Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. International Journal of Hyperthermia 2017;33:582-92. [DOI: 10.1080/02656736.2017.1291999] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Roth L, Eshmuminov D, Russo L, Laminger F, Kober F, Roka S, Lehmann K. Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC. World J Surg Oncol 2023;21:5. [PMID: 36631814 DOI: 10.1186/s12957-022-02884-9] [Reference Citation Analysis]
2 Liesenfeld LF, Quiring E, Al-saeedi M, Nusshag C, Büchler MW, Schneider M. Extensive Peritonectomy is an Independent Risk Factor for Cisplatin HIPEC-Induced Acute Kidney Injury. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12661-3] [Reference Citation Analysis]
3 Ramos Arias G, Sindayigaya R, Ouaissi M, Buggisch JR, Schmeding M, Giger-pabst U, Zieren J. Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12698-4] [Reference Citation Analysis]
4 Wu MF, Liang JX, Li H, Ye YF, Liang WF, Wang LJ, Zhang BZ, Chen Q, Lin ZQ, Li J. Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high-grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study. BJOG 2022;129 Suppl 2:5-13. [PMID: 36485072 DOI: 10.1111/1471-0528.17323] [Reference Citation Analysis]
5 Wu Y, Zheng X, Sun C, Wang S, Ding S, Wu M, Zhang J, Wang B, Xue L, Yang L, Tian Y, Xie Y. Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01795-6] [Reference Citation Analysis]
6 Lim PQ, Han IH, Seow KM, Chen KH. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers. Int J Mol Sci 2022;23:10078. [PMID: 36077477 DOI: 10.3390/ijms231710078] [Reference Citation Analysis]
7 Baron C, Buchholz M, Majchrzak-stiller B, Peters I, Fein D, Müller T, Uhl W, Höhn P, Strotmann J, Braumann C. Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma—A 3-D In Vitro Study. IJMS 2022;23:7293. [DOI: 10.3390/ijms23137293] [Reference Citation Analysis]
8 Harper MM, Kim J, Pandalai PK. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies. J Clin Med 2022;11:2840. [PMID: 35628966 DOI: 10.3390/jcm11102840] [Reference Citation Analysis]
9 Khan H, Johnston FM. Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease. J Surg Oncol 2022;125:1176-82. [PMID: 35481913 DOI: 10.1002/jso.26894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gronau F, Feldbruegge L, Oberwittler F, Gonzalez-Moreno S, Villeneuve L, Eveno C, Glehen O, Kusamura S, Rau B. HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques. J Clin Med 2022;11:1456. [PMID: 35268546 DOI: 10.3390/jcm11051456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Batista TP, Carneiro VCG, Tancredi R, Badiglian Filho L, Rangel RLC, Lopes A, Sarmento BJQ, Leão CS. A phase 2 trial of short-course Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) at interval cytoreductive surgery (iCRS) for advanced ovarian cancer. Rev Col Bras Cir 2022;49:e20223135. [PMID: 35239855 DOI: 10.1590/0100-6991e-20223135] [Reference Citation Analysis]
12 Mazurek M, Szlendak M, Forma A, Baj J, Maciejewski R, Roviello G, Marano L, Roviello F, Polom K, Sitarz R. Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review. Int J Environ Res Public Health 2022;19:681. [PMID: 35055500 DOI: 10.3390/ijerph19020681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Löke DR, Helderman RFCPA, Franken NAP, Oei AL, Tanis PJ, Crezee J, Kok HP. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy. Drug Deliv 2021;28:145-61. [PMID: 33427507 DOI: 10.1080/10717544.2020.1862364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
14 Bhatt A, de Hingh I, Van Der Speeten K, Hubner M, Deraco M, Bakrin N, Villeneuve L, Kusamura S, Glehen O. HIPEC Methodology and Regimens: The Need for an Expert Consensus. Ann Surg Oncol 2021. [PMID: 34142293 DOI: 10.1245/s10434-021-10193-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
15 Cashin PH, Graf W. Sequential postoperative intraperitoneal chemotherapy for colorectal cancer with peritoneal metastases: a narrative review. J Gastrointest Oncol 2021;12:S131-5. [PMID: 33968433 DOI: 10.21037/jgo-20-137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Christou N, Auger C, Battu S, Lalloué F, Jauberteau-Marchan MO, Hervieu C, Verdier M, Mathonnet M. Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives. Biology (Basel) 2021;10:225. [PMID: 33804167 DOI: 10.3390/biology10030225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chan CY, Li H, Wu MF, Liu CH, Lu HW, Lin ZQ, Li J. A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy. Front Oncol 2021;11:616264. [PMID: 33777754 DOI: 10.3389/fonc.2021.616264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang WY, Wu MF, Wu DB, Wang LJ, Li H, Lin ZQ, Li J. Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients. J Ovarian Res 2021;14:9. [PMID: 33419462 DOI: 10.1186/s13048-021-00764-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Brind'Amour A, Dubé P, Tremblay JF, Soucisse ML, Mack L, Bouchard-Fortier A, McCart JA, Govindarajan A, Bischof D, Haase E, Giacomantonio C, Hebbard P, Younan R, MacNeill A, Boulanger-Gobeil C, Sidéris L. Canadian guidelines on the management of colorectal peritoneal metastases. Curr Oncol 2020;27:e621-31. [PMID: 33380878 DOI: 10.3747/co.27.6919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Abdel Mageed H. On the need to standardize intraperitoneal chemotherapy. Eur J Surg Oncol 2021;47:1227. [PMID: 33131970 DOI: 10.1016/j.ejso.2020.10.024] [Reference Citation Analysis]
21 Kireeva G, Kruglov S, Maydin M, Gubareva E, Fedoros E, Zubakina E, Ivanenko N, Bezruchko M, Solovyev N. Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution. Molecules 2020;25:E4733. [PMID: 33076418 DOI: 10.3390/molecules25204733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Sorrentino L, Serra F, Cabry F, Cauteroq N, Zmora O, Gelmini R. Peritoneal carcinomatosis from colorectal cancer in the pediatric population: Cytoreductive surgery and HIPEC. A systematic review. Eur J Surg Oncol 2021;47:211-5. [PMID: 32888733 DOI: 10.1016/j.ejso.2020.08.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Schooneveldt G, Löke DR, Zweije R, Helderman RF, Kok HP, Crezee H. Experimental validation of a thermophysical fluid model for use in a hyperthermia treatment planning system. International Journal of Heat and Mass Transfer 2020;152:119495. [DOI: 10.1016/j.ijheatmasstransfer.2020.119495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Schredl P, Ramspott JP, Neureiter D, Emmanuel K, Jäger T. The PEritoneal SUrface CAlculator (PESUCA): A new tool to quantify the resected peritoneal surface area after cytoreductive surgery. Pleura Peritoneum 2020;5:20190031. [PMID: 32885035 DOI: 10.1515/pp-2019-0031] [Reference Citation Analysis]
25 Govaerts K, Van der Speeten K, Bijelic L, Esquivel J. The Basis of Regional Therapy, Pharmacology, Hyperthermia, and Drug Resistance. Cancer Regional Therapy 2020. [DOI: 10.1007/978-3-030-28891-4_1] [Reference Citation Analysis]
26 Berger Y, Mogal H, Turaga K. Peritoneal Perfusion Techniques. Cancer Regional Therapy 2020. [DOI: 10.1007/978-3-030-28891-4_17] [Reference Citation Analysis]
27 Glasgow SC, Gaertner W, Stewart D, Davids J, Alavi K, Paquette IM, Steele SR, Feingold DL. The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms. Dis Colon Rectum 2019;62:1425-38. [PMID: 31725580 DOI: 10.1097/DCR.0000000000001530] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
28 Langstraat C. Review of the Outcomes of Ovarian Cancer Treated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy. Indian J Gynecol Oncolog 2019;17:94. [DOI: 10.1007/s40944-019-0342-x] [Reference Citation Analysis]
29 De Clercq K, Xie F, De Wever O, Descamps B, Hoorens A, Vermeulen A, Ceelen W, Vervaet C. Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer. Sci Rep 2019;9:14881. [PMID: 31619730 DOI: 10.1038/s41598-019-51419-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
30 Lemoine L, Thijssen E, Carleer R, Geboers K, Sugarbaker P, van der Speeten K. Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial. J Surg Oncol 2019;119:999-1010. [PMID: 30838646 DOI: 10.1002/jso.25437] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
31 Lemoine L, Thijssen E, Carleer R, Cops J, Lemmens V, Eyken PV, Sugarbaker P, der Speeten KV. Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization. Oncotarget 2019;10:1407-24. [PMID: 30858926 DOI: 10.18632/oncotarget.26667] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
32 Yurttas C, Hoffmann G, Tolios A, Haen SP, Schwab M, Königsrainer I, Königsrainer A, Beckert S, Löffler MW. Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer. J Clin Med 2018;7:E567. [PMID: 30572653 DOI: 10.3390/jcm7120567] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
33 Mielko J, Rawicz-pruszynski K, Jastrzebski T, Polkowski WP. Advances in surgery for peritoneal surface malignancies. Current Issues in Pharmacy and Medical Sciences 2017;30:171-2. [DOI: 10.1515/cipms-2017-0031] [Reference Citation Analysis]
34 Kusamura S, Sinukumar S, Baratti D, Guaglio M, Guadagni S, Deraco M. Cytoreductive Surgery and HIPEC in the First-Line and Interval Time Points of Advanced Epithelial Ovarian Cancer. Indian J Gynecol Oncolog 2017;15:11-20. [DOI: 10.1007/s40944-017-0148-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bespalov VG, Alvovsky IK, Tochilnikov GV, Stukov AN, Vyshinskaya EA, Semenov AL, Vasilyeva IN, Belyaeva OA, Kireeva GS, Senchik KY, Zhilinskaya NT, Von JD, Krasilnikova LA, Alexandrov VA, Khromov-Borisov NN, Baranenko DA, Belyaev AM. Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer. Int J Hyperthermia 2018;34:545-50. [PMID: 28893108 DOI: 10.1080/02656736.2017.1375161] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]